NSG6020 Final Exam Prep Document | 2026/2027 Edition |
150 Verified Questions - 142 Questions with Answers
NSG6020 Final Exam 2026-142 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100% Verified Solutions
| Updated Per Latest Guidelines | Graded A+
This comprehensive study guide is meticulously crafted for nursing students preparing for the
NSG6020 final exam. It contains 150 verified questions with correct answers and detailed rationales,
covering all major domains of advanced health assessment. The content is aligned with the latest
2026/2027 academic guidelines, ensuring relevance and accuracy. Each question is designed to test
critical thinking and clinical reasoning, providing a thorough review of the course material. This
document is an essential resource for achieving a high score and mastering the competencies required
for advanced practice nursing.
Key Features:
Advanced Health Assessment Foundations
Interviewing and Health History Taking
Physical Examination Techniques (Inspection, Palpation, Percussion, Auscultation)
Assessment of Mental Health and Neurological Status
Head, Eyes, Ears, Nose, and Throat (HEENT) Assessment
Cardiovascular and Peripheral Vascular Assessment
Respiratory and Thorax Assessment
Abdominal and Gastrointestinal Assessment
Musculoskeletal and Neurological Assessment
Integumentary and Lymphatic Assessment
Endocrine and Metabolic Assessment
Reproductive and Genitourinary Assessment
Pediatric and Geriatric Considerations
Cultural and Lifespan Variations in Assessment
Documentation and Clinical Reasoning
Integration of Evidence-Based Practice in Assessment
Updates for 2026:
- Updated to reflect 2026/2027 academic standards and guidelines
- Incorporated latest evidence-based practice recommendations
- Revised rationales to enhance clarity and educational value
- Added new questions on emerging health assessment topics
- Aligned with current NCLEX and advanced practice exam blueprints
Abstract:
This exam preparation document for NSG6020 provides a rigorous and comprehensive review of advanced health
assessment. It encompasses 150 carefully selected questions that mirror the format and difficulty of the final exam.
The content is organized to systematically cover all major body systems, developmental stages, and cultural
considerations, ensuring a holistic approach. Each question is accompanied by a correct answer and a detailed
rationale that explains the underlying pathophysiology and clinical reasoning. The document is designed to
reinforce key concepts, identify knowledge gaps, and build confidence. By engaging with this material, students
will enhance their diagnostic acumen and readiness for the exam. The rationales are written to promote deep
understanding rather than rote memorization. This resource is an indispensable tool for any student aiming to
Page 1
,excel in NSG6020 and in future clinical practice.
Keywords:
NSG6020, Advanced Health Assessment, Final Exam, Verified Questions, Rationales, 2026/2027, Nursing, Clinical
Reasoning
Answer Format:
Each question is presented in a multiple-choice format with four options. The correct answer is clearly indicated,
followed by a comprehensive rationale explaining why it is correct and why the distractors are incorrect. Rationales
include relevant pathophysiology, clinical guidelines, and evidence-based practice to reinforce learning.
Compliance Checklist:
All questions verified for accuracy and relevance
Aligned with latest 2026/2027 curriculum standards
Rationales cited from reputable sources
Covers all major domains of advanced health assessment
Suitable for self-assessment and exam preparation
Instant download PDF format for easy access
Content Area Overview:
Content Area Questions Key Topics Weight
Foundations of Health 1-15 Health history, communication, ethical 10%
Assessment considerations, evidence-based practice
Physical Examination 16-30 Inspection, palpation, percussion, 10%
Techniques auscultation, vital signs
Mental Health and Neurological 31-45 Mental status, cranial nerves, sensory and 10%
Assessment motor function, reflexes
HEENT Assessment 46-60 Head, eyes, ears, nose, throat, lymph nodes 10%
Cardiovascular and Peripheral 61-75 Heart sounds, pulses, jugular venous 10%
Vascular Assessment pressure, peripheral perfusion
Respiratory and Thorax 76-90 Breath sounds, respiratory effort, chest 10%
Assessment expansion, percussion
Abdominal and Gastrointestinal 91-105 Inspection, auscultation, percussion, 10%
Assessment palpation, liver and spleen size
Musculoskeletal and 106-120 Joint range of motion, muscle strength, gait, 10%
Neurological Assessment coordination
Integumentary and Lymphatic 121-135 Skin lesions, turgor, lymph node chains, 10%
Assessment edema
Special Populations and 136-150 Pediatric, geriatric, pregnant, cultural 10%
Lifespan Considerations variations, documentation
Page 2
,Q1. A patient with chronic kidney disease (CKD) stage 4 and hypertension is
prescribed an ACE inhibitor and a loop diuretic. Which laboratory finding best
indicates an adverse effect requiring immediate intervention?
A. Serum creatinine increase of 0.3 mg/dL from baseline
B. Serum potassium of 5.8 mEq/L
C. Blood urea nitrogen (BUN) of 28 mg/dL
D. Glomerular filtration rate (GFR) decrease of 10% from baseline
Correct Answer: B. Serum potassium of 5.8 mEq/L
Rationale: Hyperkalemia (K+ >5.5 mEq/L) is a life-threatening adverse effect of ACE
inhibitors, especially in CKD patients on potassium-sparing diuretics. The other options
represent expected changes or less urgent findings.
Why Wrong:
A - A small creatinine increase is common after ACE inhibitor initiation and is
acceptable if <30% from baseline.
C - BUN elevation is often seen in CKD and is not specific for an acute adverse effect.
D - A 10% GFR decrease is within acceptable limits and does not require immediate
intervention.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th ed., Ch. 24.
Q2. Which of the following best describes the pathophysiological mechanism of type 2
diabetes mellitus (T2DM) progression from prediabetes to overt hyperglycemia?
A. Autoimmune destruction of pancreatic beta cells leading to absolute insulin
deficiency
B. Progressive beta-cell dysfunction combined with increasing insulin resistance
C. Defective insulin receptor signaling solely in adipose tissue
D. Excessive glucagon secretion from alpha cells without beta-cell dysfunction
Correct Answer: B. Progressive beta-cell dysfunction combined with increasing
insulin resistance
Rationale: T2DM is characterized by a progressive decline in beta-cell function and
worsening insulin resistance, leading to hyperglycemia. Autoimmune destruction is type 1,
and isolated receptor or glucagon defects do not fully explain the disease.
Why Wrong:
A - This describes type 1 diabetes mellitus, not T2DM.
C - Insulin resistance occurs in multiple tissues, not solely adipose tissue.
D - Glucagon excess is a contributing factor but not the primary mechanism without
beta-cell dysfunction.
Reference: McCance, K.L. & Huether, S.E. (2026). Pathophysiology: The Biologic Basis
for Disease in Adults and Children, 9th ed., Ch. 19.
Page 3
, Q3. A patient with atrial fibrillation is started on warfarin. Which pharmacogenomic
factor most significantly influences the required maintenance dose?
A. CYP2C9 and VKORC1 polymorphisms
B. CYP3A4 and P-glycoprotein activity
C. N-acetyltransferase 2 (NAT2) genotype
D. HLA-B*5701 allele presence
Correct Answer: A. CYP2C9 and VKORC1 polymorphisms
Rationale: Warfarin is metabolized by CYP2C9 and acts on VKORC1; variants in these
genes alter dose requirements and bleeding risk. The other options are relevant to other
drugs (e.g., clopidogrel, isoniazid, abacavir).
Why Wrong:
B - CYP3A4 metabolizes many drugs but is not the primary determinant of warfarin
dose.
C - NAT2 is involved in isoniazid metabolism, not warfarin.
D - HLA-B*5701 is associated with abacavir hypersensitivity, not warfarin dosing.
Reference: Whirl-Carrillo, M. et al. (2026). Pharmacogenomics Knowledge Base
(PharmGKB).
Q4. A 30-year-old patient presents with acute chest pain, hypotension, and jugular
venous distension. An ECG shows low-voltage QRS complexes. Which of the
following is the most likely diagnosis?
A. Acute myocardial infarction
B. Pericardial effusion with cardiac tamponade
C. Pulmonary embolism
D. Aortic dissection
Correct Answer: B. Pericardial effusion with cardiac tamponade
Rationale: The triad of hypotension, JVD, and low-voltage QRS is classic for cardiac
tamponade due to pericardial effusion. MI, PE, and dissection may cause hypotension but
do not typically produce low-voltage QRS.
Why Wrong:
A - MI may cause chest pain and hypotension but usually shows ST changes, not
low-voltage QRS.
C - PE can cause hypotension and JVD but typically shows right heart strain patterns,
not low-voltage QRS.
D - Aortic dissection presents with tearing pain and pulse deficits, not low-voltage
QRS.
Reference: Marx, J.A. et al. (2026). Rosen's Emergency Medicine, 10th ed., Ch. 26.
Page 4
150 Verified Questions - 142 Questions with Answers
NSG6020 Final Exam 2026-142 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100% Verified Solutions
| Updated Per Latest Guidelines | Graded A+
This comprehensive study guide is meticulously crafted for nursing students preparing for the
NSG6020 final exam. It contains 150 verified questions with correct answers and detailed rationales,
covering all major domains of advanced health assessment. The content is aligned with the latest
2026/2027 academic guidelines, ensuring relevance and accuracy. Each question is designed to test
critical thinking and clinical reasoning, providing a thorough review of the course material. This
document is an essential resource for achieving a high score and mastering the competencies required
for advanced practice nursing.
Key Features:
Advanced Health Assessment Foundations
Interviewing and Health History Taking
Physical Examination Techniques (Inspection, Palpation, Percussion, Auscultation)
Assessment of Mental Health and Neurological Status
Head, Eyes, Ears, Nose, and Throat (HEENT) Assessment
Cardiovascular and Peripheral Vascular Assessment
Respiratory and Thorax Assessment
Abdominal and Gastrointestinal Assessment
Musculoskeletal and Neurological Assessment
Integumentary and Lymphatic Assessment
Endocrine and Metabolic Assessment
Reproductive and Genitourinary Assessment
Pediatric and Geriatric Considerations
Cultural and Lifespan Variations in Assessment
Documentation and Clinical Reasoning
Integration of Evidence-Based Practice in Assessment
Updates for 2026:
- Updated to reflect 2026/2027 academic standards and guidelines
- Incorporated latest evidence-based practice recommendations
- Revised rationales to enhance clarity and educational value
- Added new questions on emerging health assessment topics
- Aligned with current NCLEX and advanced practice exam blueprints
Abstract:
This exam preparation document for NSG6020 provides a rigorous and comprehensive review of advanced health
assessment. It encompasses 150 carefully selected questions that mirror the format and difficulty of the final exam.
The content is organized to systematically cover all major body systems, developmental stages, and cultural
considerations, ensuring a holistic approach. Each question is accompanied by a correct answer and a detailed
rationale that explains the underlying pathophysiology and clinical reasoning. The document is designed to
reinforce key concepts, identify knowledge gaps, and build confidence. By engaging with this material, students
will enhance their diagnostic acumen and readiness for the exam. The rationales are written to promote deep
understanding rather than rote memorization. This resource is an indispensable tool for any student aiming to
Page 1
,excel in NSG6020 and in future clinical practice.
Keywords:
NSG6020, Advanced Health Assessment, Final Exam, Verified Questions, Rationales, 2026/2027, Nursing, Clinical
Reasoning
Answer Format:
Each question is presented in a multiple-choice format with four options. The correct answer is clearly indicated,
followed by a comprehensive rationale explaining why it is correct and why the distractors are incorrect. Rationales
include relevant pathophysiology, clinical guidelines, and evidence-based practice to reinforce learning.
Compliance Checklist:
All questions verified for accuracy and relevance
Aligned with latest 2026/2027 curriculum standards
Rationales cited from reputable sources
Covers all major domains of advanced health assessment
Suitable for self-assessment and exam preparation
Instant download PDF format for easy access
Content Area Overview:
Content Area Questions Key Topics Weight
Foundations of Health 1-15 Health history, communication, ethical 10%
Assessment considerations, evidence-based practice
Physical Examination 16-30 Inspection, palpation, percussion, 10%
Techniques auscultation, vital signs
Mental Health and Neurological 31-45 Mental status, cranial nerves, sensory and 10%
Assessment motor function, reflexes
HEENT Assessment 46-60 Head, eyes, ears, nose, throat, lymph nodes 10%
Cardiovascular and Peripheral 61-75 Heart sounds, pulses, jugular venous 10%
Vascular Assessment pressure, peripheral perfusion
Respiratory and Thorax 76-90 Breath sounds, respiratory effort, chest 10%
Assessment expansion, percussion
Abdominal and Gastrointestinal 91-105 Inspection, auscultation, percussion, 10%
Assessment palpation, liver and spleen size
Musculoskeletal and 106-120 Joint range of motion, muscle strength, gait, 10%
Neurological Assessment coordination
Integumentary and Lymphatic 121-135 Skin lesions, turgor, lymph node chains, 10%
Assessment edema
Special Populations and 136-150 Pediatric, geriatric, pregnant, cultural 10%
Lifespan Considerations variations, documentation
Page 2
,Q1. A patient with chronic kidney disease (CKD) stage 4 and hypertension is
prescribed an ACE inhibitor and a loop diuretic. Which laboratory finding best
indicates an adverse effect requiring immediate intervention?
A. Serum creatinine increase of 0.3 mg/dL from baseline
B. Serum potassium of 5.8 mEq/L
C. Blood urea nitrogen (BUN) of 28 mg/dL
D. Glomerular filtration rate (GFR) decrease of 10% from baseline
Correct Answer: B. Serum potassium of 5.8 mEq/L
Rationale: Hyperkalemia (K+ >5.5 mEq/L) is a life-threatening adverse effect of ACE
inhibitors, especially in CKD patients on potassium-sparing diuretics. The other options
represent expected changes or less urgent findings.
Why Wrong:
A - A small creatinine increase is common after ACE inhibitor initiation and is
acceptable if <30% from baseline.
C - BUN elevation is often seen in CKD and is not specific for an acute adverse effect.
D - A 10% GFR decrease is within acceptable limits and does not require immediate
intervention.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th ed., Ch. 24.
Q2. Which of the following best describes the pathophysiological mechanism of type 2
diabetes mellitus (T2DM) progression from prediabetes to overt hyperglycemia?
A. Autoimmune destruction of pancreatic beta cells leading to absolute insulin
deficiency
B. Progressive beta-cell dysfunction combined with increasing insulin resistance
C. Defective insulin receptor signaling solely in adipose tissue
D. Excessive glucagon secretion from alpha cells without beta-cell dysfunction
Correct Answer: B. Progressive beta-cell dysfunction combined with increasing
insulin resistance
Rationale: T2DM is characterized by a progressive decline in beta-cell function and
worsening insulin resistance, leading to hyperglycemia. Autoimmune destruction is type 1,
and isolated receptor or glucagon defects do not fully explain the disease.
Why Wrong:
A - This describes type 1 diabetes mellitus, not T2DM.
C - Insulin resistance occurs in multiple tissues, not solely adipose tissue.
D - Glucagon excess is a contributing factor but not the primary mechanism without
beta-cell dysfunction.
Reference: McCance, K.L. & Huether, S.E. (2026). Pathophysiology: The Biologic Basis
for Disease in Adults and Children, 9th ed., Ch. 19.
Page 3
, Q3. A patient with atrial fibrillation is started on warfarin. Which pharmacogenomic
factor most significantly influences the required maintenance dose?
A. CYP2C9 and VKORC1 polymorphisms
B. CYP3A4 and P-glycoprotein activity
C. N-acetyltransferase 2 (NAT2) genotype
D. HLA-B*5701 allele presence
Correct Answer: A. CYP2C9 and VKORC1 polymorphisms
Rationale: Warfarin is metabolized by CYP2C9 and acts on VKORC1; variants in these
genes alter dose requirements and bleeding risk. The other options are relevant to other
drugs (e.g., clopidogrel, isoniazid, abacavir).
Why Wrong:
B - CYP3A4 metabolizes many drugs but is not the primary determinant of warfarin
dose.
C - NAT2 is involved in isoniazid metabolism, not warfarin.
D - HLA-B*5701 is associated with abacavir hypersensitivity, not warfarin dosing.
Reference: Whirl-Carrillo, M. et al. (2026). Pharmacogenomics Knowledge Base
(PharmGKB).
Q4. A 30-year-old patient presents with acute chest pain, hypotension, and jugular
venous distension. An ECG shows low-voltage QRS complexes. Which of the
following is the most likely diagnosis?
A. Acute myocardial infarction
B. Pericardial effusion with cardiac tamponade
C. Pulmonary embolism
D. Aortic dissection
Correct Answer: B. Pericardial effusion with cardiac tamponade
Rationale: The triad of hypotension, JVD, and low-voltage QRS is classic for cardiac
tamponade due to pericardial effusion. MI, PE, and dissection may cause hypotension but
do not typically produce low-voltage QRS.
Why Wrong:
A - MI may cause chest pain and hypotension but usually shows ST changes, not
low-voltage QRS.
C - PE can cause hypotension and JVD but typically shows right heart strain patterns,
not low-voltage QRS.
D - Aortic dissection presents with tearing pain and pulse deficits, not low-voltage
QRS.
Reference: Marx, J.A. et al. (2026). Rosen's Emergency Medicine, 10th ed., Ch. 26.
Page 4
